Report Overview
Report Overview
Gene therapy is the therapeutic delivery of nucleic acid into a patients cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.The gene therapies for tumor treatment market is driven by the growing need for targeted and personalized cancer therapies and the increasing focus on innovative treatment approaches. Gene therapies involve the introduction of therapeutic genes into cancer cells to target and destroy tumors or inhibit their growth. The rise in the incidence of cancer and the limitations of conventional cancer treatments contribute to market growth. Moreover, advancements in gene editing technology and the understanding of tumor genetics have improved the development of effective gene therapies. However, the market also faces challenges, including the complexity of tumor heterogeneity and the potential for off-target effects in gene editing. Additionally, addressing regulatory and ethical considerations and ensuring accessibility and affordability can pose obstacles for widespread adoption. To succeed, companies must focus on research and development to offer safe and efficient gene therapies, collaborate with oncology centers to conduct clinical trials and address specific tumor types, and address the challenges to meet the increasing demand for effective and transformative cancer treatments.
The global Gene Therapies for Tumor Treatment market size was estimated at USD 7976.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 20.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapies for Tumor Treatment market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapies for Tumor Treatment market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapies for Tumor Treatment market.
Global Gene Therapies for Tumor Treatment Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Market Segmentation (by Type)
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapies for Tumor Treatment Market
Overview of the regional outlook of the Gene Therapies for Tumor Treatment Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapies for Tumor Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapies for Tumor Treatment, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Gene Therapies for Tumor Treatment
- 1.2 Key Market Segments
- 1.2.1 Gene Therapies for Tumor Treatment Segment by Type
- 1.2.2 Gene Therapies for Tumor Treatment Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Gene Therapies for Tumor Treatment Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Gene Therapies for Tumor Treatment Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Gene Therapies for Tumor Treatment Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Gene Therapies for Tumor Treatment Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Gene Therapies for Tumor Treatment Product Life Cycle
- 3.3 Global Gene Therapies for Tumor Treatment Sales by Manufacturers (2020-2025)
- 3.4 Global Gene Therapies for Tumor Treatment Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Gene Therapies for Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Gene Therapies for Tumor Treatment Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Gene Therapies for Tumor Treatment Market Competitive Situation and Trends
- 3.8.1 Gene Therapies for Tumor Treatment Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Gene Therapies for Tumor Treatment Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Gene Therapies for Tumor Treatment Industry Chain Analysis
- 4.1 Gene Therapies for Tumor Treatment Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Gene Therapies for Tumor Treatment Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Gene Therapies for Tumor Treatment Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Gene Therapies for Tumor Treatment Market
- 5.7 ESG Ratings of Leading Companies
- 6 Gene Therapies for Tumor Treatment Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Type (2020-2025)
- 6.3 Global Gene Therapies for Tumor Treatment Market Size by Type (2020-2025)
- 6.4 Global Gene Therapies for Tumor Treatment Price by Type (2020-2025)
- 7 Gene Therapies for Tumor Treatment Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Gene Therapies for Tumor Treatment Market Sales by Application (2020-2025)
- 7.3 Global Gene Therapies for Tumor Treatment Market Size (M USD) by Application (2020-2025)
- 7.4 Global Gene Therapies for Tumor Treatment Sales Growth Rate by Application (2020-2025)
- 8 Gene Therapies for Tumor Treatment Market Sales by Region
- 8.1 Global Gene Therapies for Tumor Treatment Sales by Region
- 8.1.1 Global Gene Therapies for Tumor Treatment Sales by Region
- 8.1.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Region
- 8.2 Global Gene Therapies for Tumor Treatment Market Size by Region
- 8.2.1 Global Gene Therapies for Tumor Treatment Market Size by Region
- 8.2.2 Global Gene Therapies for Tumor Treatment Market Size by Region
- 8.3 North America
- 8.3.1 North America Gene Therapies for Tumor Treatment Sales by Country
- 8.3.2 North America Gene Therapies for Tumor Treatment Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Gene Therapies for Tumor Treatment Sales by Country
- 8.4.2 Europe Gene Therapies for Tumor Treatment Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Gene Therapies for Tumor Treatment Sales by Region
- 8.5.2 Asia Pacific Gene Therapies for Tumor Treatment Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Gene Therapies for Tumor Treatment Sales by Country
- 8.6.2 South America Gene Therapies for Tumor Treatment Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Gene Therapies for Tumor Treatment Sales by Region
- 8.7.2 Middle East and Africa Gene Therapies for Tumor Treatment Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Gene Therapies for Tumor Treatment Sales by Region
- 9 Gene Therapies for Tumor Treatment Market Production by Region
- 9.1 Global Production of Gene Therapies for Tumor Treatment by Region(2020-2025)
- 9.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Region (2020-2025)
- 9.3 Global Gene Therapies for Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Gene Therapies for Tumor Treatment Production
- 9.4.1 North America Gene Therapies for Tumor Treatment Production Growth Rate (2020-2025)
- 9.4.2 North America Gene Therapies for Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Gene Therapies for Tumor Treatment Production
- 9.5.1 Europe Gene Therapies for Tumor Treatment Production Growth Rate (2020-2025)
- 9.5.2 Europe Gene Therapies for Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Gene Therapies for Tumor Treatment Production (2020-2025)
- 9.6.1 Japan Gene Therapies for Tumor Treatment Production Growth Rate (2020-2025)
- 9.6.2 Japan Gene Therapies for Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Gene Therapies for Tumor Treatment Production (2020-2025)
- 9.7.1 China Gene Therapies for Tumor Treatment Production Growth Rate (2020-2025)
- 9.7.2 China Gene Therapies for Tumor Treatment Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Novartis
- 10.1.1 Novartis Basic Information
- 10.1.2 Novartis Gene Therapies for Tumor Treatment Product Overview
- 10.1.3 Novartis Gene Therapies for Tumor Treatment Product Market Performance
- 10.1.4 Novartis Business Overview
- 10.1.5 Novartis SWOT Analysis
- 10.1.6 Novartis Recent Developments
- 10.2 Gilead Sciences
- 10.2.1 Gilead Sciences Basic Information
- 10.2.2 Gilead Sciences Gene Therapies for Tumor Treatment Product Overview
- 10.2.3 Gilead Sciences Gene Therapies for Tumor Treatment Product Market Performance
- 10.2.4 Gilead Sciences Business Overview
- 10.2.5 Gilead Sciences SWOT Analysis
- 10.2.6 Gilead Sciences Recent Developments
- 10.3 Amgen
- 10.3.1 Amgen Basic Information
- 10.3.2 Amgen Gene Therapies for Tumor Treatment Product Overview
- 10.3.3 Amgen Gene Therapies for Tumor Treatment Product Market Performance
- 10.3.4 Amgen Business Overview
- 10.3.5 Amgen SWOT Analysis
- 10.3.6 Amgen Recent Developments
- 10.4 Shanghai Sunway
- 10.4.1 Shanghai Sunway Basic Information
- 10.4.2 Shanghai Sunway Gene Therapies for Tumor Treatment Product Overview
- 10.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Product Market Performance
- 10.4.4 Shanghai Sunway Business Overview
- 10.4.5 Shanghai Sunway Recent Developments
- 10.5 Sibiono
- 10.5.1 Sibiono Basic Information
- 10.5.2 Sibiono Gene Therapies for Tumor Treatment Product Overview
- 10.5.3 Sibiono Gene Therapies for Tumor Treatment Product Market Performance
- 10.5.4 Sibiono Business Overview
- 10.5.5 Sibiono Recent Developments
- 10.1 Novartis
- 11 Gene Therapies for Tumor Treatment Market Forecast by Region
- 11.1 Global Gene Therapies for Tumor Treatment Market Size Forecast
- 11.2 Global Gene Therapies for Tumor Treatment Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Gene Therapies for Tumor Treatment Market Size Forecast by Country
- 11.2.3 Asia Pacific Gene Therapies for Tumor Treatment Market Size Forecast by Region
- 11.2.4 South America Gene Therapies for Tumor Treatment Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Gene Therapies for Tumor Treatment by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Gene Therapies for Tumor Treatment Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Gene Therapies for Tumor Treatment by Type (2026-2035)
- 12.1.2 Global Gene Therapies for Tumor Treatment Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Gene Therapies for Tumor Treatment by Type (2026-2035)
- 12.2 Global Gene Therapies for Tumor Treatment Market Forecast by Application (2026-2035)
- 12.2.1 Global Gene Therapies for Tumor Treatment Sales (K MT) Forecast by Application
- 12.2.2 Global Gene Therapies for Tumor Treatment Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Gene Therapies for Tumor Treatment Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings